Outcome and Genomic Characteristics of Non-Down Syndrome Acute Megakaryoblastic Leukemia in Children Treated with Low-Dose Chemotherapy for Induction Remission

被引：0
|
作者：
Hu, Yixin [1 ]
Gao, Li
Chen, Aili [2 ]
Lu, Jun [1 ]
Li, Jie [1 ]
He, Hailong [1 ]
Wang, Yi [1 ]
Xiao, Peifang [1 ]
Wang, Qianfei [2 ]
Ribeiro, Raul [3 ]
Hu, Shaoyan [1 ]
机构：
[1] Soochow Univ, Dept Pediat Hematol & Oncol, Childrens Hosp, Suzhou, Peoples R China
[2] Chinese Acad Sci, Beijing Inst Genom, Collaborat Innovat Ctr Genet & Dev, Key Lab Genom & Precis Med, Beijing, Peoples R China
[3] St Jude Childrens Res Hosp, Dept Oncol & Global Med, Int Outreach Program, 332 N Lauderdale St, Memphis, TN 38105 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-129572
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2613
引用
收藏
页数：3
相关论文
共 50 条
  • [41] LOW-DOSE CYTOSINE-ARABINOSIDE AS REMISSION INDUCTION THERAPY IN REFRACTORY ADULT ACUTE LYMPHOCYTIC-LEUKEMIA
    ONUNDARSON, PT
    ROWE, JM
    AMERICAN JOURNAL OF MEDICINE, 1989, 86 (04): : 493 - 494
  • [42] LOW-DOSE ARA-C CAN CAUSE COMPLETE REMISSION OF ACUTE NONLYMPHOCYTIC LEUKEMIA - DIFFERENTIATION INDUCTION
    YE, JS
    FENG, GH
    LIANG, GR
    TAO, MX
    LEUKEMIA RESEARCH, 1986, 10 (10) : 1221 - 1224
  • [43] Durable clinical and cytogenetic remission in an elderly patient with relapsed acute myeloid leukemia treated with low-dose lenalidomide
    Basile, Frank G.
    LEUKEMIA & LYMPHOMA, 2009, 50 (04) : 653 - 655
  • [44] Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study
    Flasinski, Marius
    Scheibke, Kira
    Zimmermann, Martin
    Creutzig, Ursula
    Reinhardt, Katarina
    Verwer, Femke
    de Haas, Valerie
    van der Velden, Vincent H. J.
    von Neuhoff, Christine
    Zwaan, C. Michel
    Reinhardt, Dirk
    Klusmann, Jan-Henning
    BLOOD ADVANCES, 2018, 2 (13) : 1532 - 1540
  • [45] Frequency, Risk Factors, Underlying Causes and Outcome of Seizures in Children During Induction Remission Chemotherapy for Acute Lymphoblastic Leukemia
    Jamal, C. Y.
    Soma, S. A.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S124 - S124
  • [46] LOW-DOSE COMBINATION REMISSION INDUCTION THERAPY FOR ACUTE MYELOID-LEUKEMIA IN ELDERLY PATIENTS - A PILOT-STUDY
    MANOHARAN, A
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1992, 22 (06): : 710 - 711
  • [47] LOW-DOSE CYTOSINE-ARABINOSIDE - PARTIAL REMISSION OF ACUTE MYELOID-LEUKEMIA WITHOUT EVIDENCE OF DIFFERENTIATION INDUCTION
    LEYDEN, M
    MANOHARAN, A
    BOYD, A
    CHENG, ZM
    SULLIVAN, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1984, 57 (02) : 301 - 307
  • [48] LOW-DOSE CYTOSINE-ARABINOSIDE - PARTIAL REMISSION OF ACUTE MYELOID-LEUKEMIA WITHOUT EVIDENCE OF DIFFERENTIATION INDUCTION
    LEYDEN, M
    MANOHARAN, A
    BOYD, A
    CHENG, Z
    SULLIVAN, J
    PATHOLOGY, 1984, 16 (03) : 364 - 364
  • [49] Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study
    Whitlock, JA
    Sather, HN
    Gaynon, P
    Robison, LL
    Wells, RJ
    Trigg, M
    Heerema, NA
    Bhatia, S
    BLOOD, 2005, 106 (13) : 4043 - 4049
  • [50] Ecological principle meets cancer treatment: treating children with acute myeloid leukemia with low-dose chemotherapy
    Yixin Hu
    Aili Chen
    Xinchang Zheng
    Jun Lu
    Hailong He
    Jin Yang
    Ya Zhang
    Pinpin Sui
    Jingyi Yang
    Fuhong He
    Yi Wang
    Peifang Xiao
    Xin Liu
    Yinmei Zhou
    Deqing Pei
    Cheng Cheng
    Raul C.Ribeiro
    Shaoyan Hu
    Qian-fei Wang
    NationalScienceReview, 2019, 6 (03) : 469 - 479
12345